Back to Search
ROBERT SMITH, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1366648776Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Clinical Trials (4)
4
Linked Trials
0
Recruiting
3
With Results
Varenicline Effects In Schizophrenic Smokers
NCT00548470COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
NCT00231894COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
NCT00802919COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
NCT00287820COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Nicotine receptor partial agonists for smoking cessation.
PMID 37142273·Cochrane Database Syst Rev·2023
1-meta
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
PMID 26730716·PLoS One·2016
4-observational
Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
PMID 23200554·Schizophr Res·2013
2-rct
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
PMID 22475524·Psychiatry Res·2012
2-rct
Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
PMID 20457512·Schizophr Res·2010
2-rct
Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.
PMID 19814947·J Clin Psychiatry·2009
4-observational
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
PMID 19251401·Schizophr Res·2009
3-trial
In vitro macrophage response to polyethylene and polycarbonate-urethane particles.
PMID 19569215·J Biomed Mater Res A·2010
8-other
In vivo response to cross-linked polyethylene and polycarbonate-urethane particles.
PMID 19557792·J Biomed Mater Res A·2010
7-preclinical
The isozyme-specific effects of cyclooxygenase-deficiency on bone in mice.
PMID 16875891·Bone·2006
7-preclinical
Adhesion of microvascular endothelial cells to metallic implant surfaces.
PMID 15348024·J Mater Sci Mater Med·2000
8-other
Evidence for new endothelial cell binding sites on fibrinogen.
PMID 11127863·Thromb Haemost·2000
8-other
Pathology of an islet transplant 2 years after transplantation: evidence for a nonimmunological loss.
PMID 18622278·Transplantation·2008
5-case
Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage.
PMID 18488420·Int J Nanomedicine·2008
8-other
Quantitation and kinetics of CD51 surface receptor expression: implications for targeted delivery.
PMID 15171619·Ann Biomed Eng·2004
4-observational
Cell-based screening: a high throughput flow cytometry platform for identification of cell-specific targeting molecules.
PMID 15032661·Comb Chem High Throughput Screen·2004
8-other
Increases in avoidance responding produced by REM sleep deprivation or serotonin depletion are reversed by administration of 5-hydroxytryptophan.
PMID 12644281·Behav Brain Res·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 920 MADISON AVENUE SUITE 447
MEMPHIS, TN 38163 - Phone
- (901) 448-0230
Quick Facts
- NPI
- 1366648776
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile